Lidocaine 5% patch 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F96Z9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,113
Award facts
- Contract value 100% obligated
- $6,113.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,113.16 to AmerSourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count units) with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs this work at its corporate office location. The award is a child task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain operations, which provides critical pharmaceutical and medical commodities to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare institutions. Lidocaine patches are commonly used topical analgesics in military treatment facilities and veteran healthcare programs for localized pain management. The parent company, Cencora, Inc. (doing business as AmerSourceBergen), maintains a separate $999,999,999.00 IDC with DLA Troop Support Medical that extends through December 2031, demonstrating the company's extensive role as a primary pharmaceutical vendor for federal military and healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DR26F96Z9?
SPE2DR26F96Z9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F96Z9 worth?
The government has obligated $6,113 on SPE2DR26F96Z9.
Is contract SPE2DR26F96Z9 an order under another contract?
Yes. SPE2DR26F96Z9 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96Z9 competed?
The extent of competition for SPE2DR26F96Z9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award